Results 101 to 110 of about 127,286 (242)
Caregiver outcomes (hours, ZBI, EQ-VAS, EQ-5D-3L) by patient dementia severity.
Caregiver outcomes (hours, ZBI, EQ-VAS, EQ-5D-3L) by patient dementia severity.
Xiaohan Hu (1674277) +6 more
core +1 more source
Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients [PDF]
Aims: To date, evidence to support the construct validity of the EQ-5D-5L has primarily focused on cross-sectional data. The aims of this study were to examine the responsiveness of EQ-5D-5L in patients with stroke and to compare it with responsiveness ...
Buczek, J +13 more
core +2 more sources
A cationic poly(disulfide)‐drug nanoplatform (LA/DexP) was developed to treat experimental autoimmune uveitis (EAU). With potent blood‐retinal barrier penetrability, LA/DexP releases DSP in response to high ROS and scavenges cfDNA to inhibit the cGAS‐STING signaling pathway.
Yuelan Wu +12 more
wiley +1 more source
Validity and reliability of the EQ-5D-3L™ among a paediatric injury population [PDF]
The purpose of this study was to determine the construct validity of the EQ-5D-3L™ for use among a population of injured young people and to examine the reliability of different modes of administration including paper and pencil, online and telephone. Methods: In total, 345 participants (aged 0 – 16) were recruited from a paediatric hospital in a large
Brussoni, Mariana +2 more
openaire +2 more sources
ATL2 Recruits TRAK1 to Promote Mitochondrial Transport at ER–Mitochondria Contact Sites
ABSTRACT Mitochondrial transport and distribution are crucial for cellular homeostasis, yet whether and how they are regulated by endoplasmic reticulum (ER)–mitochondria contact sites remains unclear. Here, we demonstrate that the ER protein atlastin‐2 (ATL2) orchestrates mitochondrial transport and distribution by promoting assembly of the transport ...
Yiru Cheng +9 more
wiley +1 more source
A comparison of values in the EQ-5D-3L value set and the EQ-5D-5L crosswalk value set for Trinidad and Tobago.
Althea La Foucade (6645668) +3 more
core +1 more source
CuPB@HA is a CD44‐associated, plaque‐targeted nanozyme that alleviates oxidative stress, inflammation, and lipid accumulation in macrophages. By reducing CD36‐dependent lipid uptake and promoting ABCA1/ABCG1‐mediated cholesterol handling, it improves macrophage function, preferentially accumulates in atherosclerotic lesions, reduces plaque burden, and ...
Jianliang Ou +14 more
wiley +1 more source
Convergent validity of the EQ-5D-3L in a randomized-controlled trial of the Housing First model
Background Health utility assessments are important for economic evaluations but few instruments have been validated in homeless people with mental illness.
Nicole Kozloff +5 more
doaj +1 more source
International Valuation Protocol for the EQ-5D-Y-3L [PDF]
Ramos-Goni JM, Oppe M, Stolk E, et al. International Valuation Protocol for the EQ-5D-Y-3L. PharmacoEconomics. 2020;38:653-663.The EQ-5D-Y-3L is a generic, health-related, quality-of-life instrument for use in younger populations.
Oppe, M +18 more
core +1 more source
Magneto‐NIR‐II‐programmed NFSH nanozymes integrate magnetic blood–brain barrier (BBB) translocation, CD44 targeting, multimodal imaging, and cascade catalytic therapy for glioblastoma. Alternating magnetic fields and NIR‐II irradiation amplify ferroptosis, release H2S, suppress autophagic and mitophagic repair, and reshape the immune microenvironment ...
Ruocan Liu +7 more
wiley +1 more source

